+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027

  • PDF Icon

    Report

  • 145 Pages
  • January 2023
  • Region: Asia Pacific
  • Markets and Markets
  • ID: 5716873

The Asia Pacific spatial genomics and transcriptomics market is projected to reach USD 152 million by 2027 from USD 64 million in 2022, at a CAGR of 18.9% during the forecast period.

The key factors driving the growth of the spatial genomics and transcriptomics market in the Asia Pacific are growing number of consumables for various spatial genomics and transcriptomics applications, introduction of novel products, and increasing adoption of spatial genomics & transcriptomics in drug discovery & development. However, the high capital investments associated with spatial genomics and transcriptomics are expected to restrain market growth to a certain extent. The Asia Pacific spatial genomics and transcriptomics market has been segmented based on product, technique, application, end user, and country.

 By application, the translational research accounted for the largest share of the Asia Pacific spatial genomics & transcriptomics market

Based on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery & development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations. 

By technique, the spatial transcriptomics accounted for the largest share in the Asia Pacific spatial genomics & transcriptomics market

Based on technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics and spatial genomics analysis. In 2021, the spatial transcriptomics segment accounted for a larger share of the Asia Pacific spatial genomics and transcriptomics market. Growth in this market segment can be attributed to the increasing demand for and high adoption rate of in situ sequencing techniques. 

China: the largest share of the spatial genomics & transcriptomics market

China accounted for the largest share of the spatial genomics & transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding by the government and biopharma companies for the development of new regenerative medicine are the major factors driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
  • By Country: Japan- 22%, China- 47%, India- 11%, Rest of APAC- 20%

Prominent  Players

  • NanoString Technologies, Inc. (US)
  • 10X Genomics (US)
  • Illumina (US)
  • Bio-Rad Laboratories (US)
  • Bio-Techne Corporation (US)
  • Standard BioTools Inc. (US)
  •  Genomic Vision SA (France)
  • Akoya Biosciences, Inc. (US)
  •  S2 Genomics (US)
  • Cantata Bio (US)
  • Vizgen Group (US)
  • BGI Group (China)
  • Miltenyi Biotec (Germany)
  • Bruker (US)
  • Perkinelmer Inc. (US)
  • Novogene Co., Ltd. (China)

Research Coverage:

This report provides a detailed picture of the spatial genomics & trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and country. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies. 

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

Frequently Asked Questions about the APAC Spatial Genomics & Transcriptomics Market

What is the estimated value of the APAC Spatial Genomics & Transcriptomics Market?

The APAC Spatial Genomics & Transcriptomics Market was estimated to be valued at $64 Million in 2022.

What is the growth rate of the APAC Spatial Genomics & Transcriptomics Market?

The growth rate of the APAC Spatial Genomics & Transcriptomics Market is 18.9%, with an estimated value of $152 Million by 2027.

What is the forecasted size of the APAC Spatial Genomics & Transcriptomics Market?

The APAC Spatial Genomics & Transcriptomics Market is estimated to be worth $152 Million by 2027.

Who are the key companies in the APAC Spatial Genomics & Transcriptomics Market?

Key companies in the APAC Spatial Genomics & Transcriptomics Market include 10X Genomics, Akoya Biosciences, Bgi Group, Bio, Rad Laboratories, Inc., Bio, Techne, Bruker and Illumina.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Study Scope
1.4 Years Considered
1.5 Currency Considered
1.6 Limitations
1.7 Stakeholders

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 2 Breakdown of Primaries: Asia-Pacific Spatial Genomics and Transcriptomics Market
2.2 Market Estimation Methodology
Figure 3 Market Size Estimation (Company Revenue Analysis-Based Estimation)
Figure 4 Asia-Pacific Spatial Genomics and Transcriptomics Market Size (USD Million)
Figure 5 Asia-Pacific Spatial Genomics and Transcriptomics Market: Final CAGR Projections (2022−2027)
Figure 6 Asia-Pacific Spatial Genomics and Transcriptomics Market: CAGR Projections from Analysis of Demand-Side Drivers, Restraints, Opportunities, and Challenges
2.3 Market Data Estimation and Triangulation
Figure 7 Data Triangulation Methodology
2.4 Industry Insights
2.5 Research Assumptions

3 Executive Summary
Figure 8 Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, 2022 Vs. 2027 (USD Million)
Figure 9 Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technique, 2022 Vs. 2027 (USD Million)
Figure 10 Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, 2022 Vs. 2027 (USD Million)
Figure 11 Asia-Pacific Spatial Genomics and Transcriptomics Market, by End-User, 2022 Vs. 2027 (USD Million)
Figure 12 Asia-Pacific Spatial Genomics and Transcriptomics Market Share, by Country, 2021

4 Premium Insights
4.1 Asia-Pacific Spatial Genomics and Transcriptomics Market Overview
Figure 13 Reduced Cost of Next-Generation Sequencing to Drive Market Growth
4.2 Japan: Spatial Genomics and Transcriptomics Market Share, by Product (2021)
Figure 14 Consumables Segment Dominated Market in Japan
4.3 China: Spatial Genomics and Transcriptomics Market Share, by Application (2021)
Figure 15 Translational Research Segment Dominated Market in China

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 16 Asia-Pacific Spatial Genomics and Transcriptomics Market: Drivers, Restraints, Opportunities, and Challenges
Table 1 Asia-Pacific Spatial Genomics and Transcriptomics Market: Impact Analysis
5.2.1 Drivers
5.2.1.1 Reduced Cost of Next-Generation Sequencing
5.2.1.2 Increasing Adoption of Spatial Genomics and Transcriptomics in Drug Discovery and Development
5.2.2 Restraints
5.2.2.1 High Capital Investments
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Single-Cell Analysis
5.2.4 Challenges
5.2.4.1 Analytical Limitations Associated with Spatial Techniques
5.3 Technology Analysis
Table 2 Five Benchmark Computational Methods: Comparative Analysis
5.4 Value Chain Analysis
Table 3 Indicative List of Distributors for Key Market Players in Asia-Pacific
Figure 17 Asia-Pacific Spatial Genomics and Transcriptomics Market: Value Chain Analysis
5.5 Ecosystem Analysis
Figure 18 Spatial Genomics and Transcriptomics Market: Ecosystem Analysis
5.6 Porter's Five Forces Analysis
Table 4 Asia-Pacific Spatial Genomics and Transcriptomics Market: Porter's Five Forces Analysis
5.6.1 Threat of New Entrants
5.6.2 Threat of Substitutes
5.6.3 Bargaining Power of Buyers
5.6.4 Bargaining Power of Suppliers
5.6.5 Intensity of Competitive Rivalry
5.7 Regulatory Analysis
5.7.1 Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 Asia-Pacific: List of Regulatory Bodies, Government Agencies, and Other Organizations
5.8 Pricing Analysis
Table 6 Product Pricing: Key Market Players
5.8.1 Average Selling Price Trend
5.9 Key Conferences and Events (2020-2023)
Table 7 Spatial Genomics and Transcriptomics Conferences (2020-2023)
5.10 Key Stakeholders and Buying Criteria
5.10.1 Key Stakeholders in Buying Process
Figure 19 Influence of Stakeholders on Buying Process
5.10.2 Buying Criteria for Spatial Genomics and Transcriptomics Market in Asia-Pacific Region
Figure 20 Key Buying Criteria for End-Users

6 Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product
6.1 Introduction
Table 8 Asia-Pacific: Spatial Genomics and Transcriptomics Market, by Product, 2020-2027 (USD Million)
6.2 Consumables
6.2.1 Growing Use of Consumables for Various Spatial Genomics and Transcriptomics Applications to Drive Growth
Table 9 Asia-Pacific: Spatial Genomics and Transcriptomics Consumables Market, by Country, 2020-2027 (USD Million)
6.3 Instruments
6.3.1 Introduction of Novel Instruments to Drive Market
Table 10 Asia-Pacific: Spatial Genomics and Transcriptomics Instruments Market, by Country, 2020-2027 (USD Million)
6.4 Software
6.4.1 Rising Use of Spatial Omics for Disease Diagnosis to Propel Demand for Software
Table 11 Asia-Pacific: Spatial Genomics and Transcriptomics Software Market, by Country, 2020-2027 (USD Million)

7 Spatial Genomics and Transcriptomics Market, by Technique
7.1 Introduction
Table 12 Asia-Pacific: Spatial Genomics and Transcriptomics Market, by Technique, 2020-2027 (USD Million)
7.2 Spatial Transcriptomics
Table 13 Asia-Pacific: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 14 Asia-Pacific: Spatial Transcriptomics Market, by Country, 2020-2027 (USD Million)
7.2.1 Immunohistochemistry
7.2.1.1 Emergence of Mihc/If to Propel Growth
Table 15 Asia-Pacific: Immunohistochemistry Market, by Country, 2020-2027 (USD Million)
7.2.2 in Situ Hybridization
7.2.2.1 High Adoption of Merfish to Drive Growth
Table 16 Asia-Pacific: in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
7.2.3 Spatial Transcriptomic Sequencing
Table 17 Asia-Pacific: Spatial Transcriptomic Sequencing Market, by Country, 2020-2027 (USD Million)
7.2.3.1 Microdissection-Based Sequencing
7.2.3.1.1 Increasing Use of Microdissection-Based Sequencing to Contribute to Market Growth
7.2.3.2 in Situ Sequencing
7.2.3.2.1 Increased Adoption of in Situ Sequencing Likely to Boost Market Growth
7.2.3.3 Other Sequencing Technologies
7.2.4 Microscopy-Based Rna Imaging
7.2.4.1 Increasing Use of Microscopy-Based Rna Imaging in Cancer Research and Diagnosis to Drive Growth
Table 18 Asia-Pacific: Microscopy-Based Rna Imaging Market, by Country, 2020-2027 (USD Million)
7.2.5 Other Spatial Transcriptomics Techniques
Table 19 Asia-Pacific: Spatial Transcriptomics Market for Other Techniques, by Country, 2020-2027 (USD Million)
7.3 Spatial Genomics Analysis
Table 20 Asia-Pacific: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 21 Asia-Pacific: Spatial Genomics Analysis Market, by Country, 2020-2027 (USD Million)
7.3.1 Fluorescence in Situ Hybridization
7.3.1.1 Emerging Potential of Spatial Genomics Analysis in Cancer Diagnostics to Support Growth
Table 22 Asia-Pacific: Fluorescence in Situ Hybridization Market, by Country, 2020-2027 (USD Million)
7.3.2 Spatial Genomic Sequencing
7.3.2.1 Rising Adoption of Massively Parallel Sequencing to Drive Growth
Table 23 Asia-Pacific: Spatial Genomic Sequencing Market, by Country, 2020-2027 (USD Million)
7.3.3 Other Spatial Genomics Analysis Techniques
Table 24 Asia-Pacific: Other Spatial Genomics Analysis Techniques Market, by Country, 2020-2027 (USD Million)

8 Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application
8.1 Introduction
Table 25 Asia-Pacific: Spatial Genomics and Transcriptomics Market, by Application, 2020-2027 (USD Million)
8.2 Translational Research
8.2.1 Demand for Spatial Transcriptomics in Understanding Tumor Microenvironment to Drive Growth
Table 26 Asia-Pacific: Spatial Genomics and Transcriptomics Market for Translational Research, by Country, 2020-2027 (USD Million)
8.3 Drug Discovery and Development
8.3.1 Rising Use of Rna-Seq in Drug Discovery to Drive Growth
Table 27 Asia-Pacific: Spatial Genomics and Transcriptomics Market for Drug Discovery and Development, by Country, 2020-2027 (USD Million)

9 Asia-Pacific Spatial Genomics and Transcriptomics Market, by End-User
9.1 Introduction
Table 28 Asia-Pacific: Spatial Genomics and Transcriptomics Market, by End-User, 2020-2027 (USD Million)
9.2 Academic and Research Institutes
9.2.1 Increasing Demand for Spatial Genomics and Transcriptomics in Translational Research to Drive Growth
Table 29 Asia-Pacific: Spatial Genomics and Transcriptomics Market for Academic and Research Institutes, by Country, 2020-2027 (USD Million)
9.3 Contract Research Organizations
9.3.1 Increasing Number of Cros Forming Strategic Partnerships with Genomics Providers to Drive Growth
Table 30 Asia-Pacific: Spatial Genomics and Transcriptomics Market for Contract Research Organizations, by Country, 2020-2027 (USD Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Growing Importance of Biomarkers to Drive Demand for Spatial Genomics and Transcriptomics Systems
Table 31 Asia-Pacific: Spatial Genomics and Transcriptomics Market for Pharmaceutical and Biotechnology Companies, by Country, 2020-2027 (USD Million)

10 Asia-Pacific Spatial Genomics and Transcriptomics Market, by Country
10.1 Introduction
Table 32 Asia-Pacific: Spatial Genomics and Transcriptomics Market, by Country, 2020-2027 (USD Million)
10.2 China
10.2.1 Increasing R&D Spending by Government and Biopharma Companies to Support Market Growth
Table 33 China: Spatial Genomics and Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 34 China: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 35 China: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 36 China: Spatial Genomics and Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 37 China: Spatial Genomics and Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 38 China: Spatial Genomics and Transcriptomics Market, by End-User, 2020-2027 (USD Million)
10.3 Japan
10.3.1 Rising Funding in Japan to Boost Research Applications
Table 39 Japan: Spatial Genomics and Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 40 Japan: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 41 Japan: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 42 Japan: Spatial Genomics and Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 43 Japan: Spatial Genomics and Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 44 Japan: Spatial Genomics and Transcriptomics Market, by End-User, 2020-2027 (USD Million)
10.4 India
10.4.1 Collaborations Between Hospitals and Diagnostic Centers for Laboratory Services to Boost Growth
Table 45 India: Spatial Genomics and Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 46 India: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 47 India: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 48 India: Spatial Genomics and Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 49 India: Spatial Genomics and Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 50 India: Spatial Genomics and Transcriptomics Market, by End-User, 2020-2027 (USD Million)
10.5 Rest of Asia-Pacific
Table 51 Rest of Asia-Pacific: Spatial Genomics and Transcriptomics Market, by Technique, 2020-2027 (USD Million)
Table 52 Rest of Asia-Pacific: Spatial Transcriptomics Market, by Type, 2020-2027 (USD Million)
Table 53 Rest of Asia-Pacific: Spatial Genomics Analysis Market, by Type, 2020-2027 (USD Million)
Table 54 Rest of Asia-Pacific: Spatial Genomics and Transcriptomics Market, by Product, 2020-2027 (USD Million)
Table 55 Rest of Asia-Pacific: Spatial Genomics and Transcriptomics Market, by Application, 2020-2027 (USD Million)
Table 56 Rest of Asia-Pacific: Spatial Genomics and Transcriptomics Market, by End-User, 2020-2027 (USD Million)

11 Competitive Landscape
11.1 Introduction
11.2 Right-To-Win Strategies Adopted by Key Players
Figure 21 Spatial Genomics and Transcriptomics Market: Strategies Adopted by Key Players
11.3 Revenue Share Analysis (Top Six Players)
11.4 Market Share Analysis (2021)
11.5 Company Evaluation Matrix
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
Figure 24 Spatial Genomics and Transcriptomics Market: Company Evaluation Matrix (2021)
11.6 Competitive Scenario and Trends
11.6.1 Deals
Table 57 Asia-Pacific Spatial Genomics and Transcriptomics Market: Deals
11.6.1.1 Product Launches
Table 58 Asia-Pacific Spatial Genomics and Transcriptomics Market: Product Launches
11.6.1.2 Other Developments
Table 59 Asia-Pacific Spatial Genomics and Transcriptomics Market: Other Developments

12 Company Profiles
12.1 Key Players
(Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 Nanostring
Table 60 Nanostring: Business Overview
Figure 25 Nanostring: Company Snapshot (2021)
12.1.2 10X Genomics
Table 61 10X Genomics: Business Overview
Figure 26 10X Genomics: Company Snapshot (2021)
12.1.3 Illumina
Table 62 Illumina: Business Overview
Figure 27 Illumina: Company Snapshot (2021)
12.1.4 Bio-Rad Laboratories, Inc.
Table 63 Bio-Rad Laboratories, Inc.: Business Overview
Figure 28 Bio-Rad Laboratories, Inc.: Company Snapshot (2021)
12.1.5 Bio-Techne
Table 64 Bio-Techne: Business Overview
Figure 29 Bio-Techne: Company Snapshot (2021)
12.1.6 Standard Biotools
Table 65 Standard Biotools: Business Overview
Figure 30 Standard Biotools: Company Snapshot (2021)
12.1.7 Akoya Biosciences
Table 66 Akoya Biosciences: Business Overview
Figure 31 Akoya Biosciences: Company Snapshot (2021)
12.1.8 S2 Genomics
Table 67 S2 Genomics: Business Overview
12.1.9 Cantata Bio
Table 68 Cantata Bio: Business Overview
12.1.10 Vizgen Corp.
Table 69 Vizgen: Business Overview
12.2 Other Players
12.2.1 Bgi Group
12.2.2 Miltenyi Biotec
12.2.3 Bruker
12.2.4 Perkinelmer Inc.
12.2.5 Novogene Co. Ltd.

*Details on Business Overview, Products Offered, Recent Developments, and Analyst's View (Key Strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) Might Not be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Executive Summary

Companies Mentioned

  • 10X Genomics
  • Akoya Biosciences
  • Bgi Group
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • Bruker
  • Cantata Bio
  • Illumina
  • Miltenyi Biotec
  • Nanostring
  • Novogene Co. Ltd.
  • Perkinelmer Inc.
  • S2 Genomics
  • Standard Biotools
  • Vizgen Corp.

Methodology

Loading
LOADING...